JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
Scope & Guideline
Leading the Charge in Enzyme Research
Introduction
Aims and Scopes
- Enzyme Inhibition Research:
The journal publishes articles that explore the mechanisms, efficacy, and selectivity of various enzyme inhibitors, focusing on their potential therapeutic applications in diseases such as cancer, diabetes, and infectious diseases. - Medicinal Chemistry:
Papers often highlight the design, synthesis, and biological evaluation of novel compounds that act as enzyme inhibitors, showcasing the intersection of chemistry and biological efficacy. - Computational Drug Design and Molecular Modelling:
The journal features studies that utilize computational methods, such as molecular docking and dynamics simulations, to predict the efficacy and selectivity of enzyme inhibitors, aiding in the rational design of new drugs. - Natural Products and Derivatives:
Research on natural compounds and their derivatives as enzyme inhibitors is prominently featured, emphasizing the exploration of traditional medicine and natural sources for novel therapeutic agents. - Targeted and Multi-targeted Therapeutics:
The journal explores the development of multi-targeted inhibitors that can simultaneously modulate multiple pathways, reflecting a growing trend in personalized medicine and complex disease treatment.
Trending and Emerging
- COVID-19 Therapeutics:
There has been a significant increase in research focused on developing inhibitors targeting SARS-CoV-2, particularly through enzyme inhibition strategies, reflecting the urgency and relevance of this global health crisis. - Dual and Multi-target Inhibitors:
The trend towards discovering compounds that can inhibit multiple targets simultaneously is gaining momentum, as researchers seek to create more effective treatments that can address complex disease mechanisms. - Artificial Intelligence and Machine Learning in Drug Discovery:
Increasingly, studies are incorporating AI and machine learning techniques to enhance drug discovery processes, particularly in predicting the interactions and efficacy of enzyme inhibitors. - Personalized Medicine Approaches:
Research is increasingly focusing on tailoring therapies to individual patients' profiles, particularly in cancer treatment, which has led to a rise in studies on personalized enzyme inhibitors. - Sustainable and Green Chemistry Practices:
There is a growing emphasis on sustainable practices in the synthesis of enzyme inhibitors, including the use of environmentally friendly solvents and methodologies, reflecting wider trends in the scientific community towards sustainability.
Declining or Waning
- Traditional Medicinal Approaches:
Research focusing solely on traditional medicinal compounds without extensive modification or synthetic approaches appears to be declining, as more emphasis is placed on novel synthetic pathways and targeted therapies. - Single-target Inhibitors:
The trend towards developing inhibitors that target single enzymes is waning, with a noticeable shift towards multi-target inhibitors and combination therapies that address the complexity of diseases. - Basic Mechanistic Studies:
Although foundational studies on enzyme mechanisms remain important, there is less emphasis on purely mechanistic studies without therapeutic implications, as the journal increasingly prioritizes translational research.
Similar Journals
JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH
Transforming Nature's Gifts into Scientific BreakthroughsJOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH is a prestigious publication in the field of natural products, focusing on valuable research spanning analytical chemistry, pharmacology, and complementary medicine. Published by Taylor & Francis Ltd in the United Kingdom, this journal has established itself as a key resource for academics and professionals seeking to explore advancements in drug discovery and organic chemistry. With a converged publication timeline from 1998 to 2024, the journal boasts several commendable category quartiles as of 2023, reflecting its robust standing in the research community: Q2 in Complementary and Alternative Medicine, Q3 in multiple domains including Analytical Chemistry and Organic Chemistry, and Q4 in Molecular Medicine. Although it currently does not offer open access, the journal remains a valuable compendium for empirical research and innovative studies in areas such as pharmacology and medicinal chemistry. Researchers, professionals, and students alike will find the JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH to be an essential platform for sharing groundbreaking findings and fostering collaborations that lead to significant advancements in science and health.
JOURNAL OF CHEMICAL RESEARCH
Elevating Chemistry: A Platform for Groundbreaking Studies.JOURNAL OF CHEMICAL RESEARCH, published by SAGE PUBLICATIONS LTD, serves as a pivotal platform for scholars and practitioners in the field of Chemistry. With its ISSN 1747-5198 and E-ISSN 2047-6507, this journal has established itself as a reliable source of innovative research since its inception in 2000. The journal's comprehensive scope encompasses various facets of chemical research, providing a broad spectrum of articles that foster scientific advancement and technological innovation. Ranked in the Q3 tier of miscellaneous chemistry journals in 2023, with a Scopus rank of #246 out of 408, it represents a solid outlet for emerging and established researchers alike. Although currently not an open-access journal, its rigorous peer-review process ensures that only high-quality studies are published, catering to the academic and professional community's demand for credible and impactful findings. Positioned in the vibrant research landscape of the United Kingdom, the JOURNAL OF CHEMICAL RESEARCH is dedicated to expanding the frontiers of chemical sciences and is an essential resource for anyone committed to advancing this dynamic field.
Future Medicinal Chemistry
Exploring innovative solutions in medicinal chemistry.Future Medicinal Chemistry is a premier journal dedicated to the rapidly evolving fields of drug discovery, pharmacology, and molecular medicine. Published by Newlands Press Ltd in the United Kingdom, this journal has garnered significant attention within the academic community, evidenced by its 2023 category rankings in Scopus, placing it in the Q2 quartile for Drug Discovery and the Q3 quartiles for both Molecular Medicine and Pharmacology. With an ISSN of 1756-8919 and an E-ISSN of 1756-8927, Future Medicinal Chemistry has been a cornerstone of scholarly discourse since its inception in 2009, continuously contributing to the advancement of knowledge and discussion in medicinal chemistry. The journal is committed to publishing high-quality, peer-reviewed research that addresses the challenges and innovations in drug development and therapeutic strategies, making it an essential resource for researchers, professionals, and students seeking to stay at the forefront of these critical fields. Engage with the latest findings and methodologies that shape the future of medicine by exploring the wealth of information offered within Future Medicinal Chemistry.
RSC Chemical Biology
Bridging Chemistry and Biology for Tomorrow's InnovationsRSC Chemical Biology is a prestigious journal published by the Royal Society of Chemistry, providing a significant platform for researchers in the fields of biochemistry, genetics, and molecular biology. Launched in 2020, the journal aims to disseminate high-quality research that bridges the gap between chemistry and biology, promoting interdisciplinary studies and innovations that are essential for advancements in life sciences. With an emerging impact factor and ranking in the top quartile (Q1) for multiple categories such as Biochemistry and Molecular Biology, RSC Chemical Biology holds a prominent position in the academic landscape, evidenced by its Scopus rankings placing it in the top 20% and 30% of its respective fields. Although it does not operate under an open-access model, the journal's commitment to accessibility is reflected in its rigorous peer-review process and its role in shaping future scientific discourse. Research published in this journal is vital for contributing to our understanding of complex biological processes and fostering innovations that can lead to real-world applications.
MEDICINAL RESEARCH REVIEWS
Unveiling Insights for Tomorrow’s Health SolutionsMEDICINAL RESEARCH REVIEWS, published by Wiley, is a leading journal in the fields of Drug Discovery, Molecular Medicine, and Pharmacology. With an impressive impact factor and esteemed standing in its category quartiles (Q1 in all three fields), this journal serves as a vital platform for the dissemination of cutting-edge research and reviews that drive innovation in therapeutic development and molecular health sciences. Since its inception in 1981, MEDICINAL RESEARCH REVIEWS has garnered a robust readership within the scientific community, underscored by its high rankings in Scopus – where it ranks #3 in Pharmacology and #2 in Drug Discovery, placing it within the top echelons of academic influence. Researchers, professionals, and students alike benefit from its rich content and comprehensive approaches to tackling complex medicinal challenges, making it an essential resource for those invested in advancing the frontiers of biomedical research.
Current Computer-Aided Drug Design
Transforming Pharmacology with Cutting-Edge Design TechniquesCurrent Computer-Aided Drug Design, published by BENTHAM SCIENCE PUBL LTD, is a pivotal journal dedicated to the integration of computer-aided methodologies within the drug design process. With its ISSN 1573-4099 and E-ISSN 1875-6697, this journal serves as a vital resource for researchers, professionals, and students interested in advancing the fields of pharmacology and molecular medicine. Operating under a framework that spans from 2006 to 2024, it aims to foster innovative approaches and discussions surrounding drug design strategies, computational techniques, and the therapeutic potential of novel compounds. Although it currently holds a Q4 rating in Drug Discovery and Molecular Medicine as well as a Q3 in Medicine (miscellaneous) within the 2023 category quartiles, the journal continues to enhance its visibility and relevance in the academic community. Its Scopus rankings reflect its commitment to quality research, positioning it in the context of drug discovery and molecular studies. As the field of drug design evolves, Current Computer-Aided Drug Design remains an essential platform for disseminating cutting-edge findings and facilitating collaboration among specialists aiming for significant advancements in drug development.
CURRENT DRUG TARGETS
Pioneering Discoveries in Drug DevelopmentCURRENT DRUG TARGETS is a leading peer-reviewed journal dedicated to advancements in the fields of Clinical Biochemistry, Drug Discovery, Molecular Medicine, and Pharmacology. Published by Bentham Science Publishers Ltd, this esteemed journal has solidified its position in the academic community with a 2023 Q2 ranking in several categories, highlighting its influence and relevance in drug research and development. With an ISSN of 1389-4501 and E-ISSN 1873-5592, CURRENT DRUG TARGETS facilitates the dissemination of high-quality articles that explore novel therapeutic strategies and drug design principles. Catered to researchers, professionals, and students, the journal has a commitment to advancing knowledge while addressing contemporary challenges in pharmacological sciences. As it converges from 2000 to 2024, CURRENT DRUG TARGETS remains a vital resource in understanding the complexities of drug action and interaction, making it indispensable for anyone pursuing cutting-edge research in related disciplines.
RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY
Pioneering Discoveries in Biochemistry and Organic ChemistryRussian Journal of Bioorganic Chemistry (ISSN: 1068-1620, E-ISSN: 1608-330X), published by MAIK Nauka/Interperiodica/Springer, serves as a vital resource for researchers and professionals in the fields of bioorganic chemistry, biochemistry, and organic chemistry. With a focus on the integration of organic chemistry principles with biological processes, this journal aims to disseminate significant findings and advancements from both theoretical and practical perspectives. Although currently not open access, the journal retains a dedication to high-quality, peer-reviewed content, contributing to its reputation within the academic community. The 2023 Scopus rankings position it within the Q4 category for both biochemistry and organic chemistry, indicating its critical niche within these disciplines amid a competitive landscape. Since its inception in 1996, the journal has continued to evolve, providing enriching insights and fostering collaborations among scholars and practitioners alike, with publication converging up to the year 2024. By exploring complex biomolecular interactions and the synthesis of biologically relevant compounds, the Russian Journal of Bioorganic Chemistry remains a significant platform for advancing knowledge and innovation in the life sciences.
BIOORGANIC CHEMISTRY
Elevating research standards in biochemistry and organic chemistry.BIOORGANIC CHEMISTRY, published by Academic Press Inc., a prestigious imprint of Elsevier Science, represents a cornerstone in the fields of biochemistry, organic chemistry, and drug discovery. With an impressive Scopus rank placing it in the top quartiles across critical categories—including Q2 for Biochemistry and Drug Discovery, and Q1 for Organic Chemistry—this journal has established itself as a vital resource for researchers, professionals, and students alike. Featuring a diverse array of articles that explore innovative methodologies and emerging trends from 1971 to the present, BIOORGANIC CHEMISTRY effectively bridges the gap between laboratory research and practical applications. Although not an Open Access journal, its rigorous peer-review process ensures the delivery of high-quality, impactful research that drives advances in the understanding and application of biochemistry. With an aim to facilitate scientific discourse and collaboration, it invites contributions that further the exploration of chemical processes within biological systems.
BIOCHEMICAL PHARMACOLOGY
Pioneering breakthroughs in drug development and therapeutic strategies.BIOCHEMICAL PHARMACOLOGY, published by PERGAMON-ELSEVIER SCIENCE LTD, stands as a leading international journal devoted to the advancing field of biochemical pharmacology. Since its inception in 1958, the journal has continuously offered a platform for innovative research, delivering critical insights into the interaction between biochemical processes and pharmaceutical applications, and now converges towards its 2024 edition. With an impressive Q1 ranking in both Biochemistry and Pharmacology categories, it ranks 32nd out of 313 in Pharmacology and Toxicology, and 58th out of 438 in Biochemistry according to Scopus, showcasing its significant impact within the scientific community. Researchers and professionals rely on this journal to keep abreast of essential developments, given its robust peer-review process and a comprehensive selection of articles that span experimental studies, clinical trials, and theoretical analyses. Although not an Open Access journal, it remains pivotal for those seeking to advance their knowledge in the dynamic fields of biochemistry and pharmacology. With its high impact factor and emphasis on quality research, BIOCHEMICAL PHARMACOLOGY continues to be an invaluable resource for students, researchers, and industry professionals striving to make breakthroughs in drug development and therapeutic strategies.